In medical news:

Members of the FDA’s Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesia Drug Products Advisory Committee will meet today and tomorrow to discuss high doses of opioids in outpatient settings. The meetings will include numerous presentations followed by discussion of potential regulatory changes.

Read more here.

Leave a Comment

Your email address will not be published. Required fields are marked *